The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed) |
93.865 |
PAR-23-193 |
| Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDUL) (P50 Clinical Trial Not Allowed) |
93.313, 93.865 |
RFA-HD-24-005 |
| Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)? |
93.866 |
RFA-AG-24-036 |
| Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)? |
93.866 |
RFA-AG-24-038 |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) |
93.879 |
PAR-23-183 |
| Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Biostatistics Research Center (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-23-009 |
| Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-24-022 |
| Preclinical Studies to Characterize the Impact of Toxicants on Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-24-023 |
| Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Clinical Centers (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-23-010 |
| Emergency Medicine Research Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent Clinical Trial Allowed) |
93.279, 93.853, 93.866 |
PAR-23-151 |
| Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed) |
93.855 |
RFA-AI-23-032 |
| Advancing Psychedelics Research for Treating Addiction (R61/R33 Basic Experimental Study with Humans Required) |
93.279 |
RFA-DA-24-029 |
| Understanding Gene-Environment Interactions in Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-24-021 |
| Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required) |
93.279 |
RFA-DA-24-024 |
| Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-24-028 |
| Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional) |
93.853 |
RFA-NS-23-027 |
| Analyzing Early Events in TB and TB/HIV Infection for Interventional Targets (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-23-029 |
| Alcohol Treatment and Recovery Research (R34 Clinical Trial required) |
93.273 |
PAR-23-188 |
| Early-Stage Therapy Development for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed) |
93.853, 93.866 |
RFA-NS-24-010 |
| Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) |
93.273 |
PAR-23-187 |
| Alcohol Health Services Research (R34 Clinical Trial Optional) |
93.273 |
PAR-23-186 |
| Patient Engagement Resource Centers to Inform SUD Treatment Services Research (R24 Clinical Trial Optional) |
93.279 |
RFA-DA-24-016 |
| Alcohol Health Services Research (R01 Clinical Trial Optional) |
93.273 |
PAR-23-185 |
| HIV Prevention and Alcohol (R34 Clinical Trials Optional) |
93.273 |
PAS-23-172 |
| HIV Prevention and Alcohol (R01 Clinical Trials Optional) |
93.273 |
PAS-23-173 |
| DoD Vision Focused Translational Team Science Award |
12.420 |
HT9425-23-VRP-FTTSA |
| DoD Vision Clinical Trial Award |
12.420 |
HT9425-23-VRP-CTA |
| Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) |
93.350 |
PAR-23-177 |
| Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed) |
93.866 |
PAR-23-174 |
| Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional) |
93.121, 93.242, 93.279, 93.393, 93.396, 93.847, 93.989 |
PAR-23-190 |
| HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) |
93.121, 93.242, 93.279, 93.393, 93.394, 93.396, 93.399, 93.847, 93.989 |
PAR-23-191 |
| Limited Competition: Renewal of the Longevity Consortium (U19 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-24-017 |
| Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) |
93.242, 93.855, 93.865 |
PAR-23-180 |
| HEAL Initiative Partnerships to Advance INterdisciplinary (PAIN) Training in Clinical Pain Research: The HEAL PAIN Cohort Program (T90/R90 Independent Clinical Trial Not Allowed) |
93.121, 93.213, 93.273, 93.279, 93.395, 93.398, 93.846, 93.853, 93.865, 93.866 |
RFA-NS-24-015 |
| NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required) |
93.853 |
PAR-23-142 |
| NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed) |
93.853 |
PAR-23-143 |
| BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-23-290 |
| BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-23-295 |
| INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) |
93.121, 93.233, 93.837, 93.838, 93.839, 93.840, 93.846, 93.866, 93.867 |
RFA-OD-23-016 |
| Sex Differences in Radiation Research: Models, Underlying Pathways, Biomarkers of Injury, and Medical Countermeasure Responses (U01 Clinical Trial Not Allowed) |
93.313, 93.855 |
RFA-AI-23-024 |
Search Results 641-680 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
